SANTA CLARA, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

SANTA CLARA, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other ...

SANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

Johnson & Johnson (J&J) MedTech’s Shockwave Medical has commenced the multicentre, prospective FORWARD CAD investigational device exemption (IDE) study of the Javelin coronary intravascular ...

Shockwave Medical is pioneering calcified cardiovascular disease treatment through their unique Intravascular Lithotripsy technology, approved in various countries. The company has reportedly ...

A fully independent clinical trial researchers thought might disprove a cardiac device made by Shockwave Medical, the company that Johnson & Johnson is buying for $13 billion, ended up providing some ...

Johnson & Johnson on Friday announced it would acquire heart device firm Shockwave Medical for $13.1 billion. It’s J&J’s second billion-dollar deal in the cardiovascular space in two years, following ...

ShockWave Medical's unique approach to treating calcified plaques in arteries sets it apart in cardiovascular care. For you as an investor in the United States and English-speaking markets worldwide, ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the company’s ...